We aimed to identify features associated with different disease trajectories in Alzheimer's disease (AD)-related primary progressive aphasia (PPA). We considered 23 patients diagnosed with AD-related PPA. All patients underwent neuropsychological evaluation, 18F-Fluorodeoxyglucose-PET brain scan, CSF biomarkers measurement and APOE genotype analysis at baseline and underwent neurological follow-up for a mean time of 3 years. Patients who progressed to total loss of speech (TLoS+) had greater impairment in writing and higher t-tau concentration as compared to TLoS- patients. Patients who progressed to loss of functional autonomy (LoFA+) had greater impairment in single-word comprehension as compared to patients who maintained autonomy in self-care. Furthermore, 18F-FDG-PET SPM analyses revealed different brain metabolic patterns between TLoS+ and TLoS- and between LoFA+ and LoFA-. In conclusion, linguistic profile, CSF t-tau and brain metabolic pattern might be useful tools to predict progression to total loss of speech and loss of functional autonomy in AD-related PPA patients.

Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline / Mazzeo, Salvatore; Polito, Cristina; Lassi, Michael; Bagnoli, Silvia; Mattei, Marta; Padiglioni, Sonia; Berti, Valentina; Lombardi, Gemma; Giacomucci, Giulia; Teresa De Cristofaro, Maria; Passeri, Alessandro; Ferrari, Camilla; Nacmias, Benedetta; Mazzoni, Alberto; Sorbi, Sandro; Bessi, Valentina. - In: NEUROBIOLOGY OF AGING. - ISSN 1558-1497. - 117:(2022), pp. 59-70. [10.1016/j.neurobiolaging.2022.05.002]

Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline

Salvatore Mazzeo
Primo
;
2022-01-01

Abstract

We aimed to identify features associated with different disease trajectories in Alzheimer's disease (AD)-related primary progressive aphasia (PPA). We considered 23 patients diagnosed with AD-related PPA. All patients underwent neuropsychological evaluation, 18F-Fluorodeoxyglucose-PET brain scan, CSF biomarkers measurement and APOE genotype analysis at baseline and underwent neurological follow-up for a mean time of 3 years. Patients who progressed to total loss of speech (TLoS+) had greater impairment in writing and higher t-tau concentration as compared to TLoS- patients. Patients who progressed to loss of functional autonomy (LoFA+) had greater impairment in single-word comprehension as compared to patients who maintained autonomy in self-care. Furthermore, 18F-FDG-PET SPM analyses revealed different brain metabolic patterns between TLoS+ and TLoS- and between LoFA+ and LoFA-. In conclusion, linguistic profile, CSF t-tau and brain metabolic pattern might be useful tools to predict progression to total loss of speech and loss of functional autonomy in AD-related PPA patients.
2022
Alzheimer's disease
Amyloid biomarkers
Brain metabolism
Disease progression
Neuropsychology
Primary progressive aphasia
File in questo prodotto:
File Dimensione Formato  
Mazzeo 2022 Loss of speech NBA.pdf

solo gestori archivio

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Copyright dell'editore
Dimensione 1.96 MB
Formato Adobe PDF
1.96 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/156790
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact